![Terence A. Kelly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Terence A. Kelly
Algemeen Directeur bij Perception Neuroscience Holdings, Inc.
Actieve functies van Terence A. Kelly
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Perception Neuroscience Holdings, Inc. | Algemeen Directeur | 01-11-2019 | - |
President | 01-11-2019 | - | |
Perception Neuroscience, Inc.
![]() Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Algemeen Directeur | - | - |
Loopbaan van Terence A. Kelly
Eerdere bekende functies van Terence A. Kelly
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CARDAX, INC. | Directeur/Bestuurslid | 16-06-2014 | 01-08-2021 |
Independent Dir/Board Member | 16-06-2014 | 01-08-2021 | |
CoMentis, Inc.
![]() CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Algemeen Directeur | 01-01-2011 | 01-01-2017 |
President | 01-01-2011 | 01-01-2017 | |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01-01-1990 | 01-01-2009 |
Kelly Pharma Research Consulting LLC | Oprichter | - | - |
Cardax Pharmaceuticals, Inc.
![]() Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Directeur/Bestuurslid | 17-06-2014 | - |
Opleiding van Terence A. Kelly
Rensselaer Polytechnic Institute | Undergraduate Degree |
The University of Texas at Austin | Doctorate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 11 |
Operationeel
Chief Executive Officer | 3 |
Director/Board Member | 2 |
President | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 4 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CARDAX, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Cardax Pharmaceuticals, Inc.
![]() Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Health Technology |
Kelly Pharma Research Consulting LLC | |
Perception Neuroscience Holdings, Inc. | |
CoMentis, Inc.
![]() CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Perception Neuroscience, Inc.
![]() Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Health Services |
- Beurs
- Insiders
- Terence A. Kelly
- Ervaring